Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could better dosing save critically ill kids?

NCT ID NCT02539407

First seen Nov 20, 2025 · Last updated Jun 22, 2026 · Updated 29 times

Summary

This study is looking at how anti-infective drugs work in critically ill children. The goal is to find the right doses for each child to improve treatment and reduce risks. Researchers will collect blood samples and health data from 3000 children in intensive care or immuno-hematology units.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PEDIATRIC INTENSIVE CARE UNIT are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Hospital Necker - Enfants Malades (Public Hospitals of Paris)

    RECRUITING

    Paris, 75015, France

    Contact Phone: •••-•••-••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could lead to safer, more effective dosing guidelines for anti-infectives in critically ill children.

What could go wrong

This is an observational study, not a treatment trial. It may not directly change practice, and results depend on complex data analysis.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.